摘要
在过去的几十年里,植物衍生产品(植物化学物质)被认为具有巨大的治疗潜力。在这些植物化学物质中,已经报道了不同的黄酮类化合物具有强大的抗癌活性。为了展示它们的抗癌潜力,这些类黄酮调节不同的信号通路。在这些途径中,据报道,哺乳动物雷帕霉素靶蛋白 (mTOR) 和相关的磷脂酰肌醇 3-激酶 (PI3K)/蛋白激酶 B (Akt) 信号级联反应是细胞存活、增殖和死亡/凋亡的关键调节剂。因此,针对这种级联反应可能是减轻细胞凋亡和抑制不同形式癌症增殖的理想策略。黄酮类化合物对 PI3K/Akt/mTOR 的靶向作用已在科学文献中得到充分证明。在目前的研究中,我们研究了各种黄酮类化合物的抗癌潜力,尤其是黄酮类、黄酮醇类和异黄酮类,包括芹菜素、木犀草素、黄芩素、橘皮素、表没食子儿茶素-3-没食子酸酯、染料木黄酮和黄豆苷元,尤其是处理 mTOR 靶向性。
关键词: 芹菜素、黄芩素、癌症预防、黄豆苷元、表没食子儿茶素-3-没食子酸酯、类黄酮、染料木黄酮、木犀草素、橘子素、mTOR。
Current Medicinal Chemistry
Title:mTOR Targeted Cancer Chemoprevention by Flavonoids
Volume: 28 Issue: 39
关键词: 芹菜素、黄芩素、癌症预防、黄豆苷元、表没食子儿茶素-3-没食子酸酯、类黄酮、染料木黄酮、木犀草素、橘子素、mTOR。
摘要: Over the past several decades, plant-derived products (phytochemicals) have been suggested to possess immense therapeutic potential. Among these phytochemicals, different flavonoids have been reported for their potent anticancer activity. To exhibit their anticancer potential, these flavonoids modulate different signaling pathways. Among these pathways, the mammalian target of rapamycin (mTOR) and associated phosphatidyl-inositol 3-kinase (PI3K)/protein kinase B (Akt) signaling cascade have been reported as a pivotal modulator of cell survival, proliferation, and death/apoptosis. Hence, targeting this cascade could be an ideal strategy to alleviate apoptosis and inhibit proliferation in different forms of cancer. The targeting of PI3K/Akt/mTOR by flavonoids have been well documented in the scientific literature. In the current study, we have studied the anticancer potential of various flavonoids, especially flavones, flavonols, and isoflavones that include apigenin, luteolin, baicalein, tangeretin, epigallocatechin- 3-gallate, genistein, and daidzein especially dealing with mTOR targeting.
Export Options
About this article
Cite this article as:
mTOR Targeted Cancer Chemoprevention by Flavonoids, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867327666201109122025
DOI https://dx.doi.org/10.2174/0929867327666201109122025 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer
Current Pharmaceutical Design Anti-Cancer Potential of a Novel SERM Ormeloxifene
Current Medicinal Chemistry Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis
Current Topics in Medicinal Chemistry Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
Current Topics in Medicinal Chemistry Comprehensive Analysis of Key Proteins Involved in Radioresistance of Prostate Cancer by Integrating Protein-protein Interaction Networks
Current Bioinformatics Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNFα Drug
Current Drug Safety Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets Preface
Current Pharmaceutical Design Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery <i>Circular RNA NF1-419</i> Inhibits Proliferation and Induces Apoptosis by Regulating Lipid Metabolism in Astroglioma Cells
Recent Patents on Anti-Cancer Drug Discovery SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
Current Drug Targets Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Inflammatory and Non-Inflammatory Roles for Toll-Like Receptors in Gastrointestinal Cancer
Current Pharmaceutical Design Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Current Signal Transduction Therapy